Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the Dunning rat prostate model system

Urology
R H GetzenbergC S Johnson

Abstract

Risk factors for prostate cancer (PCa)-related mortality include old age, black race, and residence in northern latitudes. The objectives of this study are to examine the in vitro and in vivo effects of 1,25-dihydroxycholecalciferol (1,25-D3) and less-hypercalcemic analogues on the Dunning rat prostate adenocarcinoma model. To evaluate the effect of 1,25-D3 on PCa in vitro, we used the highly metastatic Mat-lylu (MLL) and moderately metastatic R3327-AT-2 (AT-2) Dunning prostate cell lines, and examined effects on growth, clonogenicity, differentiation, and cell cycle. In vivo analysis included examination of the effects of these compounds on tumor growth and metastasis. Using both the 3-day MTT and 7-day clonogenic assay, 1,25-D3 demonstrated a growth inhibitory effect with a concentration for 50% inhibition (IC50) of approximately 20 microM for both MLL and AT-2. Cell cycle analysis of treated MLL cells (10 microM 1,25-D3 for 48 hours) had 25% more cells in the G0/G1 phase than did control cells. To examine the in vivo effect of 1,25-D3 and the less hypercalcemic vitamin D analogue, Ro25-6760 (or 6760), on MLL PCa growth and metastasis, tumors (5 x 10(5) cells) were implanted subcutaneously into the flank of Copenhagen rats on...Continue Reading

Citations

Jun 22, 2000·The Prostate·T R TennantC W Rinker-Schaeffer
Jul 12, 2002·The Prostate·Ann W HsingFrank Z Stanczyk
May 27, 2005·Cancer Chemotherapy and Pharmacology·Josephia R MuindiDonald L Trump
Jan 26, 2005·World Journal of Urology·Tomasz M BeerKristine M Eilers
Apr 13, 2010·Cancer Causes & Control : CCC·Christine M BarnettTomasz M Beer
Aug 28, 2010·Cancer Metastasis Reviews·Limin ShuAh-Ng Kong
May 21, 2003·Current Urology Reports·Donald Trump, Yiu-Keung Lau
Apr 6, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·John M StrotherRobert Dreicer
Mar 15, 2003·Clinica Chimica Acta; International Journal of Clinical Chemistry·Monte S Willis, Frank H Wians
Sep 17, 2002·Urology·Candace S JohnsonDonald L Trump
Oct 12, 2000·Molecular and Cellular Endocrinology·V Sung, D Feldman
Feb 8, 2003·Molecular and Cellular Endocrinology·C CrescioliM Maggi
Apr 15, 2000·Cancer Letters·M H PourgholamiD L Morris
May 7, 2003·The Journal of Steroid Biochemistry and Molecular Biology·Hesso FarhanHeide S Cross
Sep 23, 1998·The Journal of Steroid Biochemistry and Molecular Biology·A K NangiaR H Getzenberg
Aug 28, 2007·Nature Reviews. Cancer·Kristin K DeebCandace S Johnson
Aug 14, 2002·The British Journal of Dermatology·J E Osborne, P E Hutchinson
Mar 10, 2001·Journal of the National Cancer Institute·A SenchenkovM C Cabot
Nov 24, 1999·Current Opinion in Clinical Nutrition and Metabolic Care·G F Combs
Dec 15, 2004·American Journal of Clinical Oncology·Tomasz M BeerNina M Katovic
Apr 8, 2006·American Journal of Clinical Oncology·Guru Sonpavde, Thomas E Hutson
Mar 25, 2011·Chemotherapy·S LeoV Lorusso
Jul 2, 2010·Endocrinology·Josephia R MuindiCandace S Johnson
Aug 13, 2008·Endocrine Reviews·Roger BouillonMarie Demay
Aug 23, 2006·Photochemistry and Photobiology·Guo-Pei YuSteven A McCormick
Jul 18, 2009·World Journal of Gastroenterology : WJG·Kun-Chun Chiang, Tai C Chen
Nov 20, 2012·Future Medicinal Chemistry·Atsushi KittakaTai C Chen
Feb 7, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Adebusola A AlagbalaBarbara A Foster
Jan 11, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Paula A HerringKaren A Hasty
Mar 21, 2007·The Journal of Steroid Biochemistry and Molecular Biology·C S SpinaM F Holick
Nov 9, 2012·The British Journal of Radiology·C O'Hanlon Brown, J Waxman
Apr 26, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Marxa L FigueiredoLily Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.